Intrinsic Value of S&P & Nasdaq Contact Us

MapLight Therapeutics, Inc. MPLT NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
49/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$31.00
+14.7%

Stock Statistics — MPLT

MapLight Therapeutics, Inc. (MPLT) has a market capitalization of $21.33M and trades at $27.02. The 52-week range is 12.24-21.76.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -7.4, Earnings Per Share (EPS) of $-3.66.

The stock has a beta of -0.83, operates in the Healthcare sector.

Trading Data
Current Price$27.02
52-Week Range12.24-21.76
Volume162.24K
Avg Volume (30D)217.7K
Market Cap$21.33M
Beta (1Y)-0.83
Company
IPO Date2025-10-24
Employees109
CEOChristopher A. Kroeger
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS56565P1030
CUSIP56565P103
Income (Latest Year)
Gross Profit$-578K
EBITDA$-168.51M
Operating Income$-169.08M
Net Income$-161.15M
EPS$-3.66
EPS Diluted$-3.66
Shares Outstanding$44.02M
Balance Sheet (Latest Year)
Total Assets$479.51M
Current Assets$324.67M
Cash & ST Investments$305.1M
Total Liabilities$21.14M
Total Debt$5.8M
Net Debt$-40.93M
Total Equity$458.37M
Debt / Equity0.01
Valuation Ratios
P/E Ratio-7.4
P/B Ratio0.05
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message